Stephen K. Burley
{{Short description|American scientist}}
{{Infobox scientist
| name = Stephen Burley
| birth_date = {{Birth year and age|1958}}
| birth_place =
| death_date =
| death_place =
| workplaces = Rutgers University
Lilly Research Laboratories
Rockefeller University
Howard Hughes Medical Institute
| education = University of Western Ontario (BS)
Exeter College, Oxford (MS, PhD)
Harvard University (MD)
| thesis_title = Molecular arrangement in viruses studied by X-ray and neutron scattering and other physical techniques
| thesis_year = 1983
| doctoral_advisor = Andrew Miller
}}
Stephen Kevin Burley is a British-born scientist, naturalized in both Canada and the United States. He is known as an expert in structural biology, proteomics, structure/fragment based drug discovery, and clinical medicine/oncology.
He joined Rutgers, The State University of New Jersey in 2013, where he is a University Professor and Henry Rutgers Chair. Burley directs the RCSB Protein Data Bank (a member of the Worldwide Protein Data Bank), the [https://iqb.rutgers.edu Institute for Quantitative Biomedicine], and the [https://radcollaboratory.rutgers.edu Rutgers Artificial Intelligence and Data Science (RAD) Collaboratory].
Career
Burley has a Bachelor in physics from the University of Western Ontario{{cite web| url = http://www.prnewswire.com/news-releases/structural-genomix-appoints-stephen-k-burley-as-chief-scientific-officer-73660352.html| url-status = dead| archive-url = https://web.archive.org/web/20141013092115/http://www.prnewswire.com/news-releases/structural-genomix-appoints-stephen-k-burley-as-chief-scientific-officer-73660352.html| archive-date = 2014-10-13| title = Structural GenomiX Appoints Stephen K. Burley as Chief Scientific Officer -- re> SAN DIEGO, Oct. 16 /PRNewswire/ --}} and a D.Phil from Oxford University, England in Molecular Biophysics as a Rhodes scholar.{{Cite web |url=http://chem.rutgers.edu/introducing-professor-stephen-k-burley |title=Introducing Professor Stephen K. Burley | Department of Chemistry & Chemical Biology |access-date=2014-10-08 |archive-url=https://web.archive.org/web/20141014112149/http://chem.rutgers.edu/introducing-professor-stephen-k-burley |archive-date=2014-10-14 |url-status=dead }} Burley has an M.D. from Harvard Medical School.
He worked with Gregory A. Petsko and William N. Lipscomb at MIT and Harvard. He was faculty at Howard Hughes Medical Institute and Rockefeller University.
Burley co-founded Prospect Genomics, Inc,{{cite web | url=http://investing.businessweek.com/research/stocks/people/person.asp?personId=1450433&ticker=ONTY&previousCapId=31973&previousTitle=NESTLE%20SA-REG | title=Stocks | date=30 August 2023 }}{{dead link|date=April 2023|bot=medic}}{{cbignore|bot=medic}} a computational genomics pharma. He was Chief Scientific Officer of SGX Pharmaceuticals after it acquired Prospect. SGX was in turn merged with Eli Lilly in 2008 where Burley was a Distinguished Lilly Research Scholar in Lilly Research Laboratories{{Cite web |title=Stephen K. Burley, M.D., D.Phil. {{!}} Center for Integrative Proteomics Research |url=http://proteomics.rutgers.edu/public/?q=faculty/burley |archive-url=http://web.archive.org/web/20160310060729/http://proteomics.rutgers.edu:80/public/?q=faculty/burley |archive-date=2016-03-10 |access-date=2025-02-26 |website=proteomics.rutgers.edu |language=en}}
In 2012 Burley joined Rutgers {{cite web| url = http://www.njbiz.com/article/20121217/NJBIZ01/121219761/Rutgers-recruits-top-researcher-to-head-Center-for-Integrative-Proteomics-Research| title = Rutgers recruits top researcher to head Center for Integrative Proteomics Research - NJBIZ| date = 17 December 2012}} as Director of the Center for Integrative Proteomics Research and became director of the RCSB PDB (US regional data center for the worldwide PDB) in 2014, succeeding Prof. Helen Berman{{cite web |url=http://www.rcsb.org/pdb/explore/news.do?p=general_information/news_publications/news#201407151450 |title=RCSB PDB - News |website=www.rcsb.org |url-status=dead |archive-url=https://web.archive.org/web/20140903053143/http://www.rcsb.org/pdb/explore/news.do?p=general_information/news_publications/news |archive-date=2014-09-03}}
He is a member of the Editorial Board for Oncogene.{{cite web | url=https://www.nature.com/onc/editors/editorial-board | title=Editorial Board | Oncogene }}
Honors and awards
- Fellow of the Royal Society of Canada (elected 1995)